Internal Medicine Doctors in Toppenish, WA Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Dr. Aaron Daniel Anderson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600    Fax: 509-865-5783

Vlastimil Calayan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600    Fax: 509-865-5783

Petar Jamborcic, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600

Mark Farley, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600    Fax: 509-865-5783

Dr. Kathleen Kingsford Davis, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 518 W 1st Ave, Toppenish, WA 98948 Phone: 509-469-1784

Vesna Jamborcic, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600

Stephanie Hansen, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600    Fax: 509-865-5783

Dr. Reuben Rudy Ramoz, M.D., M.B.A. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Buster Rd, Toppenish, WA 98948 Phone: 509-865-2102    Fax: 509-865-4986

News Archive

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually curable with traditional therapies like surgery, radiation, and chemotherapy.

Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients

With cardiovascular disease being the No. 1 cause of death in end-stage kidney disease patients on peritoneal dialysis, a new study examined two classes of medications commonly prescribed to prevent cardiovascular events in these patients and found no significant difference in outcomes.

Study highlights disparities in care for disadvantaged children with traumatic brain injuries

Children who suffer traumatic brain injuries can face a difficult road to recovery, requiring services such as physical therapy and mental health treatment for months or years to get their young lives back on track.

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.

Read more Medical News

› Verified 6 days ago